Upper Respiratory Tract Infection: Clinical Trials

2 completed, 1 terminated, 1 withdrawn. 4 Phase 2.

By phase and status

Phase	Trials	Status
Phase 2	4	Completed 2, Terminated 1, Withdrawn 1

Follow Upper Respiratory Tract Infection: new trials by email Literature Review of Upper Respiratory Tract Infection trials Research Report on Upper Respiratory Tract Infection

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
The Effects of Bio Gelee Royale Forte on Immune Health in Healthy Adults Bio Gelee Royale Forte, Placebo - Upper Respiratory Tract Infection, URTI	Phase 2	Completed	Medex d.o.o.	100	2024-10-25	2025-04-29
The Effect of a Probiotic on Protection Against Upper Respiratory Tract Infections in Children probiotic, placebo - Upper Respiratory Tract Infection	Phase 2	Terminated	Probi AB	131	2013-08-01	2015-12-03
RI-001 in Immunosuppressed Respiratory Syncytial Virus (RSV) Infected Patients at Risk of Lower Tract RSV Illness RI-001 - Upper Respiratory Tract Infection, Lower Respiratory Tract Infection	Phase 2	Completed	ADMA Biologics, Inc.	21	2008-02-01	2013-04-24
A Study of Vapendavir Treatment of Hematopoietic Stem Cell Transplant Subjects With Symptomatic Rhinovirus Infection Vapendavir, Placebo Oral Tablet - Rhinovirus, Upper Respiratory Tract Infection	Phase 2	Withdrawn	Vaxart			2018-05-07

Narrower conditions

Respiratory Tract Infections (4)

Broader conditions

Infections (4)  ·  Respiratory Tract Diseases (4)

Interventions

Probiotics (1)  ·  royal jelly (1)

Sponsors

ADMA Biologics, Inc. (1)  ·  Medex d.o.o. (1)  ·  Probi AB (1)  ·  Vaxart (1)

Countries

Canada (2)  ·  Sweden (1)  ·  United States (1)

Top investigators

Anna Novotney-Barry (1)  ·  David Crowley, PhD (1)  ·  Upton Allen, MBBS (1)